Nutrition 21 slides by Q1 with optimism
Nutrition 21 has reported a spike in sales in its first quarter 2007 results, as it says its shift from ingredients to finished products is paying off.
Archives for November 15, 2006
New trial questions B-vitamins for CVD in high-risk women
Supplements of B-vitamins do not offer protection from cardiovascular disease, say the results of the US-based Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS) - findings that cannot be applied to the general population.
Pycnogenol may reduce edema in hypertensives on meds
Daily supplements of the French maritime park bark extract, Pycnogenol, could reduce edema, a typical side-effect of antihypertensive medications, by 36 percent in patients taking these medications, says a new study.
Omega-3 fatty acid may slash dementia risk - study
Increased bloods levels of the omega-3 fatty acid docosahexaenioc acid (DHA) could slash the risk of dementia and Alzheimer's disease, suggests a new study from the US.
US get worst health marks
Even though Americans are willing to spend money on healthy products, they are less likely than other nationalities to make long lasting behavior changes, according to a new report from Business Insights.
New Hispanic nutrition guidelines promote healthy eating
A Californian nutrition council has published guidelines for Hispanic consumers in an effort to encourage good nutrition amongst the nation's most unhealthy population.
Dark chocolate acts as aspirin, study
Cocoa can function in the same way as aspirin in preventing heart attacks, according to a new study investigating its effect on blood platelets.
Waitaki's Calcium Peptacan for joints makes Euro debut
New Zealand's Waitaki Biosciences is affirming its position in the joint health market with the European launch of a new ingredient named Calcium Peptacan at HIE in Frankfurt this week.